|The TFAP2C tfap2c (Catalog #MBS8207723) is a Blocking Peptide produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The AP2 gamma Blocking Peptide reacts with Human, Mouse, Rat, Monkey and may cross-react with other species as described in the data sheet. MyBioSource\'s AP2 gamma can be used in a range of immunoassay formats including, but not limited to, Blocking (BL). Researchers should empirically determine the suitability of the TFAP2C tfap2c for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TFAP2C tfap2c product has the following accession number(s) (GI #4507445) (NCBI Accession #NP_003213.1) (Uniprot Accession #Q92754). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The peptide is used to block Anti-AP2 gamma Antibody reactivity.
Quality Control: The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Directions for Use: Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours. Blood, Connective Tissue, Embryonic Tissue, Eye, Heart, Lung, Placenta, Prostate, Skin, Testis tissues are correlated with this protein. TFAP2C also interacts with the following gene(s): CD44, CDKN1A, CITED2, ECM1, GPX1, KCTD1, POU5F1, SETDB1, TP53. Adenocarcinoma, Breast Neoplasms, Heart Diseases, Inflammation, Leukemia, Melanoma, Necrosis, Neoplasm Metastasis, Neoplasms, Experimental, Nervous System Diseases are some of the diseases may be linked to AP2 gamma Blocking Peptide.